Indications and clinical use:
SYNFLORIX is indicated for active immunization of infants and children from 6 weeks up to 5 years of age against diseases caused by Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive 19A: 1
Not for use in adults.
Geriatrics (>65 years of age): Not studied.
Relevant warnings and precautions:
For more information:
Please consult the Product Monograph at
http://ca.gsk.com/media/591956/synflorix.pdf for important information relating to adverse reactions, drug interactions, and dosing information which have not been discussed in this piece.
To request a Product Monograph, or to report an adverse event, please call 1-800-387-7374.